{"prompt": "['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'ANNEX 7. NIS AEM Report Form 2 (Spontaneous Report)', 'Non-Interventional Study Adverse Event Report Form', 'For Protocols without Stipulated Active Collection of Adverse', 'For Pfizer internal use only', 'Events (Including Pragmatic Clinical Studies [Non-Medicinal Intervention])', 'AER # (insert when known)', 'Case #', 'Date Reported to Pfizer', 'Pfizer', '-', '-', 'PROTOCOL #', 'SUBJECT #', 'Protocol Title:', 'Initial Report', 'Indicate any supplemental form(s) used by selecting the appropriate box:', 'Country where', 'event occurred:', 'Follow-Up Report', 'Exposure During Pregnancy', 'Vaccine', 'Medical Device', 'Patient Data', 'Date of Birth:', '-', 'Height:', 'in', 'cm', 'DD-MMM-YYYY', 'Weight:', 'lb', 'kg', 'Male', 'Female', \"Patient's Race:\", 'Asian', 'Black or African American', 'Native Hawaiian or other Pacific Islander', 'American Indian or Alaska Native', 'White', 'Unknown', 'Cannot ask per local regulations, Other (specify):', \"Patient's Ethnicity:\", 'Hispanic or Latino', 'Not Hispanic or Latino', 'Unknown', 'If patient has', 'Date of Death:', 'Cause(s) of death:', 'Was an autopsy performed?', 'Yes', 'No', 'Unknown', 'died:', 'If yes, what was the autopsy determined cause of death?', 'DD-MMM-YYYY', 'ADVERSE EVENTS (If more than two, use additional copies of this page.)', 'Specify diagnosis if known, rather than symptoms or signs.', 'Adverse Event Term:', 'Date of', 'Is the event serious?', 'Yes', 'No', 'Onset: DD-MMM-YYYY', 'If yes, identify seriousness criteria below:', 'Seriousness Criteria (check ALL that apply)', 'Resulted in death', 'Life-threatening', 'Hospitalization/Prolongation of hospitalization', 'Persistent/Significant disability/incapacity', 'Congenital anomaly/Birth defect', 'Important medical event', 'Status at date of report or at death', 'Recovered', 'Recovered with sequelae', 'Recovering', 'Not Recovered', 'Unknown', '(check ONE):', 'If Recovered, or Recovered with sequelae, enter date:', 'DD-MMM-YYYY', 'NOTE: Does the reporter believe this AE may be related to a Suspect Product?', 'Yes', 'No', 'If Yes, which Suspect Product(s)?', 'Adverse Event Term:', 'Date of', 'Is the event serious?', 'Yes', '-', 'No', 'Onset: DD-MMM-YYYY', 'If yes, identify seriousness criteria below:', 'Seriousness Criteria (check ALL that apply)', 'Resulted in death', 'Life-threatening', 'Hospitalization/Prolongation of hospitalization', 'Persistent/Significant disability/incapacity', 'Congenital anomaly/Birth defect', 'Important medical event', 'Status at date of report or at death', 'Recovered', 'Recovered with sequelae', 'Recovering', 'Not Recovered', 'Unknown', '(check ONE):', 'If Recovered, or Recovered with sequelae, enter date:', 'DD-MMM-YYYY', 'NOTE: Does the reporter believe this AE may be related to a Suspect Product?', 'Yes', 'No', 'If Yes, which Suspect Product(s)?', 'Version 2.0, Effective August 2016', 'Page', 'of', 'Pfizer Confidential', 'Page 59 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'Non-Interventional Study Adverse Event Report Form', 'For Protocols without Stipulated Active Collection of Adverse', 'For Pfizer internal use only', 'Events (Including Pragmatic Clinical Studies [Non-Medicinal Intervention])', 'AER # (insert when known)', 'Case #', 'Date Reported to Pfizer', 'Pfizer', '-', '-', 'PROTOCOL #', 'SUBJECT #', 'Suspect Pfizer Product If more space is needed, use additional copies of this page.', 'Trade Name:', 'Generic Name:', 'Lot Number', 'Expiration Date', 'Interacting Product', 'AE involves a product problem', '-', '-', 'Name of Product:', 'NDC Number or PCR Number (For US Only)', 'DD-MMM-YYYY', 'INDICATION:', 'Dose', 'Units', 'Formulation', 'Route', 'Frequency', 'Start Date', 'Stop Date', 'DD-MMM-YYYY', 'DD-MMM-YYYY', 'If no stop date, check box if administration was ongoing during the event(s):', 'Last Action Taken with Suspect Product in', 'Withdrawn Permanently', 'Dose Reduced', 'Dose Not Changed', 'Unknown', 'Response to Event(s)', 'Withdrawn Temporarily', 'Dose Increased', 'Not Applicable', 'Did an AE recur with re-administration of product?', 'Yes', 'No', 'Unknown', 'Not Applicable', 'If Yes, which AE?', 'Concomitant Drugs', 'Include all concomitant products taken before the date of onset of the first event. Do not include products taken more', 'None', 'than 2 weeks before the event, used to treat the event, or taken only after event onset.', 'Unknown', 'If more space is needed, use additional copies of this page.', 'Trade Name', 'Indication', 'Dose', 'Units', 'Formulation', 'Route', 'Frequency', 'Start Date \\\\ Stop Date', '-', '-', 'Generic Name', 'DD-MMM-YYYY', '-', '-', 'DD-MMM-YYYY', 'If no stop date, check box if administration was ongoing during the event(s):', 'Trade Name', '-', '-', 'Generic Name', 'DD-MMM-YYYY', '-', '-', 'DD-MMM-YYYY', 'If no stop date, check box if administration was ongoing during the event(s):', 'Patient History', 'Provide relevant medical history below. Include other illnesses present at time of event and pre-existing medical conditions', 'None', '(e.g. allergies, previous drug reactions, alcohol/drug abuse,) If more space is needed, use additional copies of this page.', 'Unknown', 'Illness', 'Start Date \\\\ Stop Date', 'Pertinent Details (include procedures and dates)', 'If no stop date, check box', '-', 'if history/illness was', 'DD-MMM-YYYY', 'ongoing during the', 'event(s)', '-', 'DD-MMM-YYYY', '-', '-', 'DD-MMM-YYYY', '-', '-', 'DD-MMM-YYYY', 'Version 2.0, Effective August 2016', 'Page', 'of', 'Pfizer Confidential', 'Page 60 of 64']\n\n###\n\n", "completion": "END"}